Maraviroc Reduces Arterial Stiffness in PI-Treated HIV-infected Patients

The Δ32-CCR5 deletion of the CCR5 receptor is protective toward coronary artery pathology and myocardial infarction. Maraviroc (MVC), a CCR5 antagonist, was recently introduced in the therapy of HIV infection; we evaluated whether this drug could modulate the atherosclerotic burden in aviremic PI-tr...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Sci Rep
Main Authors: Piconi, Stefania, Pocaterra, Daria, Rainone, Veronica, Cossu, Maria, Masetti, Michela, Rizzardini, Giuliano, Clerici, Mario, Trabattoni, Daria
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2016
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4926207/
https://ncbi.nlm.nih.gov/pubmed/27352838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep28853
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki